Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Open-label, Multi-center Study of Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma: Wuhan University Cancer Center -NHL02 Trial
Conditions
Interventions
Low-dose involved-field radiotherapy
Involved-field radiotherapy
Locations
1
China
DiDeng
Wuhan, Hubei, China
Start Date
October 1, 2015
Primary Completion Date
October 1, 2019
Completion Date
October 1, 2025
Last Updated
December 14, 2015
NCT02153580
NCT03015896
NCT04447716
NCT04007029
NCT02797470
NCT03019640
Lead Sponsor
Di Deng
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions